Abstract
Single photon emission computed tomography (SPECT) and the dopamine (DA) transporter tracer, 2 beta-carboxymethoxy-3 beta-(4-iodophenyl)tropane ([123I][β-CIT), were used to determine DA transporter density in 1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned monkeys with varying degrees of parkinsonism. The clinical stage of parkinsonism corresponded to SPECT measures of striatal DA transporter density suggesting that more severe parkinsonism was associated with a greater degree of dopaminergic terminal degeneration. These findings are similar to those reported earlier using positron emission tomography (PET) and the DA metabolism tracer, 6-[18F]fluoro-L-m-tyrosine (FMT), indicating that both are good methods for evaluating nigrostriatal degeneration in MPTP primate models.
Original language | English (US) |
---|---|
Pages (from-to) | 184-187 |
Number of pages | 4 |
Journal | Brain research |
Volume | 832 |
Issue number | 1-2 |
DOIs | |
State | Published - Jun 19 1999 |
Keywords
- Dopamine transporter
- MPTP
- Monkey
- Parkinson's disease
- Single photon emission computed tomography
- β-CIT
ASJC Scopus subject areas
- Neuroscience(all)
- Molecular Biology
- Clinical Neurology
- Developmental Biology